As Delta Plus Variant Identified, Changes To India’s Trials Policy Could Help
Serum/AZ COVID-19 Vaccine Interval Could Be Revised
As a new Delta plus variant is identified, India’s exemption of bridging trials for imported COVID-19 vaccines could help speed up immunization efforts. The urgency to fully immunize individuals could also prompt a reduction in the interval between Serum/AstraZeneca’s COVID-19 vaccine doses
